GELS

NT 20-F - Gelteq Ltd (0001920092) (Filer)

6-K - Gelteq Ltd (0001920092) (Filer)

MELBOURNE, Australia, June 12, 2026 (GLOBE NEWSWIRE) -- Gelteq Limited ("Gelteq" or the "Company") today announced the successful completion of its veterinary palatability trials conducted in collaboration with Kemin Industries ("Kemin"), a leading U.S.-based global ingredient manufacturer. The trials were designed to optimise flavour profiles and assess canine acceptance of products powered by Gelteq® technology, the Company's proprietary gel-based delivery platform. Gelteq tested a variety of products, including a range deliberately formulated with natural bitter compounds that canines would ordinarily reject. The results demonstrated strong canine acceptance across the flavour profile

MELBOURNE, Australia, June 04, 2026 (GLOBE NEWSWIRE) -- Gelteq Limited ("Gelteq") today announced the establishment of a new Gelteq Center of Excellence in Guangdong Province, China. The Gelteq Center of Excellence will serve as a strategic regional hub enabling deeper integration with and strategic access to one of the world's fastest-growing pharmaceutical and biotechnology ecosystems. Enhancing Development Capabilities Through Regional Hub The establishment of Gelteq's Guangdong Province-based Center of Excellence will strengthen the Company's globally integrated development platform by leveraging regional infrastructure, technical expertise, and established innovation networks. The

6-K - Gelteq Ltd (0001920092) (Filer)

6-K - Gelteq Ltd (0001920092) (Filer)

2026 Outlook Strengthened by New Major Global Partnership with Sommer Ray's Imaraïs Beauty and Entrance into $730 Billion Health & Beauty Market LAS VEGAS, NV / ACCESS Newswire / May 14, 2026 / Healthy Extracts Inc. (OTCQB:HYEX), a leader in nutraceutical innovations and precision dose gummy manufacturing, reported record results for the first quarter ended March 31, 2026. Financial comparisons are to the same year-ago period unless otherwise noted.Q1 2026 Financial HighlightsNet revenue increased 73% to record $1.6 million, with the strong growth largely due to the merger with Gummy USA™ in October 2025, combined with continued technological innovation, product line and distribution channel

MELBOURNE, Australia, May 12, 2026 (GLOBE NEWSWIRE) -- Gelteq Limited ("Gelteq") today announced that it has secured strategic debt financing of up to USD $3.5 million to accelerate its commercialization, expand clinical trial activity and execute on existing revenue opportunities. Gelteq intends to use the proceeds of the financing to advance its key strategic initiatives, including scaling up clinical trial programs as Gelteq advances its pharmaceutical products through regulatory pathways and ramping up commercialization of its nutraceutical products. Gelteq believes the financing will strengthen its operational scalability and enable the Company to accelerate sales execution across k

2025 Non-GAAP Net Income Totaled $162,000 or $0.02 Per ShareRecord Results Driven by Fifth Sequential Quarter of Record-Setting Revenues, with the Momentum Setting Stage for Another Year of Double-Digit GrowthLAS VEGAS, NV / ACCESS Newswire / April 8, 2026 / Healthy Extracts Inc. (OTCQB:HYEX), a leader in nutraceutical innovations and precision dose gummy manufacturing, reported audited results for the year ended December 31, 2025. All comparisons are to the same year-ago period unless otherwise noted.2025 Financial Highlights2025 net revenue increased 45% to a record $4.5 million, with the increase due to the merger with Gummy USA™, continued technological innovation, product line and distr

Strong Annual Results Driven by Record-Setting Revenues for Fifth Quarter in a Row, Setting Stage for Another Record Year in 2026LAS VEGAS, NV / ACCESS Newswire / April 2, 2026 / Healthy Extracts Inc. (OTCQB:HYEX), a leader in nutraceutical innovations and precision dose gummy manufacturing, reported preliminary unaudited results for year ended December 31, 2025. All comparisons are to the same year-ago period unless otherwise noted.2025 Financial Highlights2025 net revenue is expected to increase 45% to a record $4.5 million, with the increase due to the merger with Gummy USA, continued technological innovation, product line and distribution channel expansion, and strengthening direct-to-co

6-K - Gelteq Ltd (0001920092) (Filer)

3 - Gelteq Ltd (0001920092) (Issuer)

3 - Gelteq Ltd (0001920092) (Issuer)

3 - Gelteq Ltd (0001920092) (Issuer)

3 - Gelteq Ltd (0001920092) (Issuer)

MELBOURNE, Australia and LAS VEGAS, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Gelteq Limited ("Gelteq") and Healthy Extracts™ Inc. ("Healthy Extracts") today announced the signing of a Memorandum of Understanding ("MoU") formalising a strategic partnership designed to accelerate the commercial rollout of next-generation gel-based nutraceutical products. The collaboration builds on Healthy Extracts' prior purchases of Gelteq-formulated products and marks the first phase of a long-term plan to bring Gelteq's proprietary gel delivery technology to large-scale US manufacturing and global distribution. Under the MoU, Healthy Extracts will leverage its established US-based nutritional manufacturing cap

MELBOURNE, Australia, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Gelteq Limited ("Gelteq" or the "Company"), a clinical and science-based developer of advanced gel-based oral delivery systems, today announced positive results from a recently completed preclinical study which evaluated medicinal cannabinoids delivery through the Company's proprietary oral gel platform. The findings demonstrate that Gelteq's platform significantly enhances the absorption and bioavailability of cannabidiol ("CBD") compared to an existing FDA approved oil-based product. The preliminary results reinforces our platform's potential to change how medicinal cannabis is delivered and experienced by patients. Despite having

MELBOURNE, Australia, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited ("Gelteq" or the "Company"), a clinical and science-based company specialising in gel-based oral delivery solutions, today announced a new partnership with the Hong Kong Flag Football Program. The partnership will integrate Gelteq's advanced hydration and sports performance formulations into the training and competition programs of the region's men's, women's, and youth national teams. The initiative underscores the increasing interest in high-performance programs throughout the region and builds on the recently announced China-focused sales agreement with Shenzhen Mana Health Management Co. Ltd., which includes minimu

6-K - Gelteq Ltd (0001920092) (Filer)

MELBOURNE, Australia, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited ("Gelteq" or the "Company"), a clinical and science based innovator in gel based oral delivery technologies, today announced that it has entered into a three year sales agreement with Shenzhen Mana Health Management Co. Ltd. ("Mana") under which Mana will distribute consumer nutritional products within China using Gelteq's proprietary gel formulation. The agreement represents a significant step forward in expanding Gelteq's nutritional product portfolio in China. Mana is a well-established distributor of healthcare and wellness products in China with a strong digital presence and a network of offline retail sales chann

MELBOURNE, Australia, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited ("Gelteq" or the "Company"), a clinical and science-based developer of advanced gel-based oral delivery systems, today announced preclinical findings demonstrating the effectiveness, flexibility, and safety profile of its proprietary gel platform. The results address a major challenge in pharmaceutical development and demonstrate that Gelteq's technology can enhance the oral delivery of oil-soluble and poorly soluble drugs. Across two complementary preclinical studies, the results showed a more rapid absorption of an oil soluble compound in Gelteq's gel base compared to an existing FDA approved reference product, with

MELBOURNE, Australia, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ:GELS) ("Gelteq") today announced that Nathan Givoni, its Chief Executive Officer, will present at the Q4 Investor Summit Virtual on December 9, 2025, where he will share updates on Gelteq's growth strategy, market positioning, and upcoming catalysts. The Investor Summit is an exclusive virtual event connecting investors with disruptive small and microcap companies. This quarter's event highlights MicroCap companies with compelling value propositions and near-term growth drivers, offering investors a focused platform for discovery. Mr. Givoni will be presenting on December 9 at 4:00 PM ET, together with hosting

MELBOURNE, Australia, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited ("Gelteq" or the "Company"), a clinical and science-based company specialising in gel-based oral delivery solutions, today announced positive preclinical results showing its proprietary gel formulation achieved substantially higher bioavailability than a leading on-market reference antihistamine product. In a comparative pharmacokinetic study, Gelteq's formulation demonstrated a 38–45% increase in systemic exposure and absorption (AUC) and markedly higher peak concentrations (Cmax), while maintaining a comparable time to peak plasma concentration (Tmax). The results of the study show Gelteq's gel-based delivery technol

LAS VEGAS, NV / ACCESS Newswire / November 14, 2025 / Healthy Extracts Inc. (OTCQB:HYEX), a leader in plant-based nutraceutical innovations, reported results for the third quarter and nine months ended September 30, 2025. All comparisons are to the same year-ago period unless otherwise noted.Q3 and 9M 2025 Financial HighlightsIn Q3 2025, net revenue increased 23% to a record for a third quarter totaling $918,000. On a first nine-month basis, net revenue increased 20% to a record $2.8 million. The growth was driven by technological innovation combined with strong direct-to-consumer and retail sales.Gross profit in the third quarter decreased 26% to $447,000 or 48.7% of net revenue. On a nine-

LAS VEGAS, NV / ACCESS Newswire / November 11, 2025 / Healthy Extracts Inc. (OTCQB:HYEX), a leader in science-based nutraceuticals and oral delivery technology for transformational health and longevity, has been invited to present at the annual fall Trickle Research Microcap Conference being held at the Topgolf Centennial in Centennial, Colorado on November 13, 2025.On the day of the event, a live stream of the conference can be viewed here. Healthy Extracts is scheduled to present at 3:06 p.m. Mountain time (5:06 p.m. Eastern time).Hosted by Trickle Research, the conference connects buy-side investors with select public companies within the microcap equities market. The exclusive, invitatio